This is a preview of subscription content, log in via an institution to check access.
References
Chapoy P. R., Angelini C., Brown W. J., Stiff J. E., Shug A. L. and Cederbaum S. D. 1980 Systemic carnitine deficiency–a treatable inherited lipid-storage disease presenting as Reye’s syndrome. N. Engl. J. Med. 303, 1389–1394.
El-Hattab A. W., Li F. Y., Shen J., Powell B. R., Bawle E. V., Adams D. J. et al. 2010 Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet. Med. 12, 19–24.
Eriksson B. O., Lindstedt S. and Nordin I. 1988 Hereditary defect in carnitine membrane transport is expressed in skin fibroblasts. Eur. J. Pediatr. 147, 662–663.
Koizumi A., Nozaki J., Ohura T., Kayo T., Wada Y., et al. 1999 Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum. Mol. Genet. 8, 2247–2254.
Lamhonwah A. M., Olpin S. E., Pollitt R. J., Vianey-Saban C., Divry P., Guffon N., et al. 2002 Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am. J. Med. Genet. 111, 271–284.
Lamhonwah A. M., Onizuka R., Olpin S. E., Muntoni F. and Tein I. 2004 OCTN2 mutation (R254X) found in Saudi Arabian kindred: recurrent mutation or ancient founder mutation? J. Inherit. Metab. Dis. 27, 473–476.
Lee N. C., Tang N. L., Chien Y. H., Chen C. A., Lin S. J., Chiu P. et al. 2010 Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol. Genet. Metab. 100, 46–50.
Magoulas P. L. and El-Hattab A. W. 2012 Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet. J. Rare Dis. 7, 68.
Nezu J., Tamai I., Oku A., Ohashi R., Yabuuchi H., Hashimoto N. et al. 1999 Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet. 21, 91–94.
Tang N. L., Ganapathy V., Wu X., Hui J., Seth P., Yuen P. M. et al. 1999 Mutations of OCTN2, an organic cation/ carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum. Mol. Genet. 8, 655– 660.
Treem W. R., Stanley C. A., Finegold D. N., Hale D. E. and Coates P. M. 1988 Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N. Engl. J. Med. 319, 1331–1336.
Acknowledgements
This work was supported by Grant-in-Aid for Scientific Research (C) (no. 20590598) and (S) (no. 17109007) from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Additional information
Toshiaki Hitomi and Norio Matsuura contributed equally to this work.
[Hitomi T., Matsuura N., Shigematsu Y., Okano, Y., Shinozaki E., Kawai M., Kobayashi H., Harada K. H. and Koizumi A. 2015 Importance of molecular diagnosis in the accurate diagnosis of systemic carnitine deficiency. J. Genet. 94, xx–xx]
Rights and permissions
About this article
Cite this article
HITOMI, T., MATSUURA, N., SHIGEMATSU, Y. et al. Importance of molecular diagnosis in the accurate diagnosis of systemic carnitine deficiency. J Genet 94, 147–150 (2015). https://doi.org/10.1007/s12041-015-0486-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-015-0486-0